About Belite Bio

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
5820 Oberlin Drive, Suite 101, San Diego, California 92121, US
Description
Information
Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.

Belite Bio Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology

Frequently Asked Questions about Belite Bio

What is Belite Bio email format?

The widely used Belite Bio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Belite Bio customer service number?

To contact Belite Bio customer service number in your country click here to find.


Who is the CEO of Belite Bio?

Tom Lin is the CEO of Belite Bio. To contact Tom Lin email at [email protected] or [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more